[Differences in left ventricular systolic performance during exercise in patients with hypertrophic cardiomyopathy and systemic hypertension]. 1985

H Kitamura, and K Furukawa, and K Nishida, and H Tsuji, and M Higami, and Y Morikawa, and T Ebizawa, and H Kunishige, and H Katsume, and H Ijichi

To evaluate differences in systolic global and regional performances of the left ventricle during exercise, multi-stage submaximal exercise echocardiography was used for 21 patients with hypertrophic cardiomyopathy (HCM) and 14 patients with systemic hypertension (HT), whose interventricular septa (IVS) were nearly the same in thickness (HCM; 16.5 +/- 2.4 mm, HT; 15.4 +/- 1.7 mm, NS). The data were compared with those of 18 normal subjects (N). During exercise, end-diastolic dimension (EDD) was increased in all three groups; however, there was no statistical differences among the three groups either at rest or during exercise. End-systolic dimension (ESD) was significantly decreased during exercise in HT (29.3 +/- 5.8 at rest to 28.1 +/- 5.8 mm at the peak exercise, p less than 0.05) and N (from 30.3 +/- 3.3 to 25.7 +/- 3.0 mm, p less than 0.001). On the other hand, ESD of HCM at rest, which was less than those of the other two groups, did not decrease with exercise (from 25.1 +/- 4.5 to 25.6 +/- 4.6 mm, NS), and rather they increased (more than 2 mm) during exercise in seven patients. The % shortening fraction (%SF) increased from rest to exercise both in HT (35.6 +/- 7.9% to 40.1 +/- 9.6%, p less than 0.001) and in N (from 35.1 +/- 4.2 to 45.9 +/- 4.7%, p less than 0.001). However, in the HCM group, the %SF, which was significantly greater at rest than in the other two groups, did not increase during exercise (42.5 +/- 6.8 to 42.5 +/- 8.8%, NS). In addition, in seven of 21 patients with HCM, the %SF increased more than 5% at the peak exercise. At rest, systolic wall thickening (%WT) of the IVS equally reduced both in HCM and HT. It increased in HT from 20.8 +/- 9.3% at rest to 24.6 +/- 12.7% at the peak exercise (p less than 0.05), but did not change in HCM (from 16.6 +/- 9.6% to 16.3 +/- 7.0%, NS). At rest, %WT of the left ventricular posterior wall (LVPW) was significantly greater in HCM than in HT. During exercise, it increased in HT (from 43.1 +/- 15.9% to 61.9 +/- 20.5%, p less than 0.01), but did not increase in HCM (from 81.0 +/- 27.7% to 85.5 +/- 29.6%, NS).(ABSTRACT TRUNCATED AT 400 WORDS)

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse

Related Publications

H Kitamura, and K Furukawa, and K Nishida, and H Tsuji, and M Higami, and Y Morikawa, and T Ebizawa, and H Kunishige, and H Katsume, and H Ijichi
September 2000, Journal of the American College of Cardiology,
H Kitamura, and K Furukawa, and K Nishida, and H Tsuji, and M Higami, and Y Morikawa, and T Ebizawa, and H Kunishige, and H Katsume, and H Ijichi
February 1986, The American journal of cardiology,
H Kitamura, and K Furukawa, and K Nishida, and H Tsuji, and M Higami, and Y Morikawa, and T Ebizawa, and H Kunishige, and H Katsume, and H Ijichi
September 1983, The American journal of medicine,
H Kitamura, and K Furukawa, and K Nishida, and H Tsuji, and M Higami, and Y Morikawa, and T Ebizawa, and H Kunishige, and H Katsume, and H Ijichi
May 1990, The American journal of cardiology,
H Kitamura, and K Furukawa, and K Nishida, and H Tsuji, and M Higami, and Y Morikawa, and T Ebizawa, and H Kunishige, and H Katsume, and H Ijichi
November 2013, Cardiovascular ultrasound,
H Kitamura, and K Furukawa, and K Nishida, and H Tsuji, and M Higami, and Y Morikawa, and T Ebizawa, and H Kunishige, and H Katsume, and H Ijichi
June 2020, Journal of the American College of Cardiology,
H Kitamura, and K Furukawa, and K Nishida, and H Tsuji, and M Higami, and Y Morikawa, and T Ebizawa, and H Kunishige, and H Katsume, and H Ijichi
March 1987, Clinical cardiology,
H Kitamura, and K Furukawa, and K Nishida, and H Tsuji, and M Higami, and Y Morikawa, and T Ebizawa, and H Kunishige, and H Katsume, and H Ijichi
October 2007, International journal of cardiology,
H Kitamura, and K Furukawa, and K Nishida, and H Tsuji, and M Higami, and Y Morikawa, and T Ebizawa, and H Kunishige, and H Katsume, and H Ijichi
June 1986, Kokyu to junkan. Respiration & circulation,
H Kitamura, and K Furukawa, and K Nishida, and H Tsuji, and M Higami, and Y Morikawa, and T Ebizawa, and H Kunishige, and H Katsume, and H Ijichi
February 1993, Journal of the American College of Cardiology,
Copied contents to your clipboard!